Elvia Cowan
CIK: 0001960048
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Vaxcyte, Inc.
Discretionary Trading P&L
Holdings
Transaction History (32 total)
- Oct 5, 2026PCVX
Vaxcyte, Inc.
Exercise(M)Direct19K shares at avg. $25.92$492K - Oct 5, 2026PCVX
Vaxcyte, Inc.
Sale(S)Direct19K shares at avg. $86.74$1.6M - Sep 8, 2026PCVX
Vaxcyte, Inc.
Tax Payment(F)Direct1.3K shares at avg. $60.36$80K - Sep 2, 2026PCVX
Vaxcyte, Inc.
Tax Payment(F)Direct326 shares at avg. $61.58$20K - Aug 31, 2026PCVX
Vaxcyte, Inc.
Tax Payment(F)Direct243 shares at avg. $60.74$15K - Apr 7, 2026PCVX
Vaxcyte, Inc.
Exercise(M)Direct3K shares at avg. $25.92$78K - Apr 7, 2026PCVX
Vaxcyte, Inc.
Sale(S)Direct3K shares at avg. $60.00$180K - Mar 17, 2026PCVX
Vaxcyte, Inc.
Sale(S)Direct405 shares at avg. $56.26$23K - Mar 17, 2026PCVX
Vaxcyte, Inc.
Sale(S)Direct1.5K shares at avg. $55.39$82K - Mar 11, 2026PCVX
Vaxcyte, Inc.
Exercise(M)Direct2.5K shares at avg. $25.92$65K - Mar 11, 2026PCVX
Vaxcyte, Inc.
Sale(S)Direct2.5K shares at avg. $58.59$146K - Mar 9, 2026PCVX
Vaxcyte, Inc.
Tax Payment(F)Direct495 shares at avg. $59.32$29K - Mar 2, 2026PCVX
Vaxcyte, Inc.
Tax Payment(F)Direct326 shares at avg. $61.98$20K - Feb 28, 2026PCVX
Vaxcyte, Inc.
Tax Payment(F)Direct243 shares at avg. $61.98$15K - Feb 26, 2026PCVX
Vaxcyte, Inc.
Award(A)Direct10.7K shares- - Feb 26, 2026PCVX
Vaxcyte, Inc.
Exercise(M)Direct7.7K shares at avg. $25.92$200K - Dec 23, 2025PCVX
Vaxcyte, Inc.
Sale(S)Direct4.9K shares at avg. $47.90$235K - Dec 23, 2025PCVX
Vaxcyte, Inc.
Sale(S)Direct6.7K shares at avg. $47.94$322K - Dec 23, 2025PCVX
Vaxcyte, Inc.
Gift(G)Direct1K shares- - Sep 8, 2025PCVX
Vaxcyte, Inc.
Tax Payment(F)Direct482 shares at avg. $32.41$16K - Sep 7, 2025PCVX
Vaxcyte, Inc.
Award(A)Direct2.8K shares- - Sep 2, 2025PCVX
Vaxcyte, Inc.
Tax Payment(F)Direct242 shares at avg. $31.56$8K - Sep 2, 2025PCVX
Vaxcyte, Inc.
Tax Payment(F)Direct325 shares at avg. $31.56$10K - Aug 29, 2025PCVX
Vaxcyte, Inc.
Award(A)DirectStock Option (right to buy)
9.7K shares- - Mar 3, 2025PCVX
Vaxcyte, Inc.
Tax Payment(F)Direct325 shares at avg. $72.10$23K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 5, 2026 | PCVX Vaxcyte, Inc. | Exercise(M) | 19,000 | $25.92 | $492,480 | Direct |
| Oct 5, 2026 | PCVX Vaxcyte, Inc. | Sale(S) | 19,000 | $86.74 | $1,648,060 | Direct |
| Sep 8, 2026 | PCVX Vaxcyte, Inc. | Tax Payment(F) | 1,327 | $60.36 | $80,098 | Direct |
| Sep 2, 2026 | PCVX Vaxcyte, Inc. | Tax Payment(F) | 326 | $61.58 | $20,075 | Direct |
| Aug 31, 2026 | PCVX Vaxcyte, Inc. | Tax Payment(F) | 243 | $60.74 | $14,760 | Direct |
| Apr 7, 2026 | PCVX Vaxcyte, Inc. | Exercise(M) | 3,000 | $25.92 | $77,760 | Direct |
| Apr 7, 2026 | PCVX Vaxcyte, Inc. | Sale(S) | 3,000 | $60.00 | $180,000 | Direct |
| Mar 17, 2026 | PCVX Vaxcyte, Inc. | Sale(S) | 405 | $56.26 | $22,787 | Direct |
| Mar 17, 2026 | PCVX Vaxcyte, Inc. | Sale(S) | 1,487 | $55.39 | $82,360 | Direct |
| Mar 11, 2026 | PCVX Vaxcyte, Inc. | Exercise(M) | 2,500 | $25.92 | $64,800 | Direct |
| Mar 11, 2026 | PCVX Vaxcyte, Inc. | Sale(S) | 2,500 | $58.59 | $146,482 | Direct |
| Mar 9, 2026 | PCVX Vaxcyte, Inc. | Tax Payment(F) | 495 | $59.32 | $29,363 | Direct |
| Mar 2, 2026 | PCVX Vaxcyte, Inc. | Tax Payment(F) | 326 | $61.98 | $20,205 | Direct |
| Feb 28, 2026 | PCVX Vaxcyte, Inc. | Tax Payment(F) | 243 | $61.98 | $15,061 | Direct |
| Feb 26, 2026 | PCVX Vaxcyte, Inc. | Award(A) | 10,681 | - | $0 | Direct |
| Feb 26, 2026 | PCVX Vaxcyte, Inc. | Exercise(M) | 7,716 | $25.92 | $199,999 | Direct |
| Dec 23, 2025 | PCVX Vaxcyte, Inc. | Sale(S) | 4,907 | $47.90 | $235,040 | Direct |
| Dec 23, 2025 | PCVX Vaxcyte, Inc. | Sale(S) | 6,716 | $47.94 | $321,931 | Direct |
| Dec 23, 2025 | PCVX Vaxcyte, Inc. | Gift(G) | 1,000 | - | - | Direct |
| Sep 8, 2025 | PCVX Vaxcyte, Inc. | Tax Payment(F) | 482 | $32.41 | $15,622 | Direct |
| Sep 7, 2025 | PCVX Vaxcyte, Inc. | Award(A) | 2,810 | - | - | Direct |
| Sep 2, 2025 | PCVX Vaxcyte, Inc. | Tax Payment(F) | 242 | $31.56 | $7,638 | Direct |
| Sep 2, 2025 | PCVX Vaxcyte, Inc. | Tax Payment(F) | 325 | $31.56 | $10,257 | Direct |
| Aug 29, 2025 | PCVX Vaxcyte, Inc. | Award(A) Stock Option (right to buy) | 9,743 | - | - | Direct |
| Mar 3, 2025 | PCVX Vaxcyte, Inc. | Tax Payment(F) | 325 | $72.10 | $23,432 | Direct |
1-25 of 32 transactions
About Cowan Elvia
Cowan Elvia (SEC CIK 0001960048) files insider reports with the SEC as SVP, Finance & CAO of Vaxcyte, Inc. (PCVX).
Signal8 holds 15 ownership filings by Cowan Elvia, all Form 4s, filed between Sep 5, 2024 and Oct 7, 2026. Those filings report 32 transactions, from Sep 3, 2024 to Oct 5, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Cowan Elvia's filings is in SAN CARLOS, CA.
Recent filings by Cowan Elvia
- Oct 5, 2026: Option exercise of PCVX shares (Form 4, code M).
- Oct 5, 2026: Open-market sale of PCVX shares (Form 4, code S).
- Sep 8, 2026: Tax withholding of PCVX shares (Form 4, code F).
- Sep 2, 2026: Tax withholding of PCVX shares (Form 4, code F).
- Aug 31, 2026: Tax withholding of PCVX shares (Form 4, code F).
Other insiders filing for Vaxcyte, Inc. (PCVX)
- Wassil Jim, EVP, Chief Scientific Ofc, COO
- PICKERING GRANT, CHIEF EXECUTIVE OFFICER
- GUGGENHIME ANDREW, PRESIDENT AND CFO
- Dhaliwal Harpreet S., Chief Technical Ops Officer
- Jodar Luis, Chief Medical Officer
- Markels John, Director